Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.414,67
0,12%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vaccinex Inc (VCNX) Vaccinex Inc (VCNX) Notizie

Vaccinex Inc

VCNX
7,47
0,57 (8,26%)
08 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/6/202414:36EDGAR2Form 8-K - Current report
06/6/202414:30GLOBEVaccinex Reports Completion of Last Patient Visit in..
31/5/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202400:00GLOBEVaccinex Reports First Quarter 2024 Financial Results and..
15/5/202423:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:36EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
14/5/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202418:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202423:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/5/202422:16EDGAR2Form 8-K - Current report
08/5/202418:29EDGAR2Form S-3/A - Registration statement under Securities Act of..
02/4/202414:30GLOBEVaccinex Reports 2023 Financial Results and Provides..
27/3/202413:30GLOBEVaccinex, Inc. Announces $1.5 Million Registered Direct..
04/3/202422:19EDGAR2Form 8-K - Current report
21/2/202416:10EDGAR2Form 8-K - Current report
21/2/202414:00GLOBEVaccinex Announces Multiple New Agreements for Access to..
15/2/202414:06EDGAR2Form 8-K - Current report
15/2/202414:00GLOBEVaccinex, Inc. Announces Reverse Stock Split
13/2/202422:30EDGAR2Form 8-K - Current report
13/2/202422:15EDGAR2Form SC 13D/A - General statement of acquisition of..
12/2/202422:22EDGAR2Form SC 13D/A - General statement of acquisition of..
09/2/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/2/202414:20EDGAR2Form 8-K/A - Current report: [Amend]
07/2/202421:43EDGAR2Form 8-K - Current report
07/2/202414:00GLOBEVaccinex Announces Pricing of $3.7 Million PIPE Financing
19/1/202422:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/1/202423:16EDGAR2Form S-3 - Registration statement under Securities Act of..
08/1/202422:16EDGAR2Form DEF 14A - Other definitive proxy statements
28/12/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202322:15EDGAR2Form PRE 14A - Other preliminary proxy statements
12/12/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:00GLOBENasdaq Grants Vaccinex Extension Until March 4, 2024 to..
13/11/202314:00GLOBEVaccinex Reports Third Quarter 2023 Financial Results and..
13/11/202313:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202314:00GLOBEVaccinex Reports Clinical Benefit in Interim Analyses from..
26/10/202315:30EDGAR2Form 8-K - Current report
26/10/202315:30GLOBEVaccinex Reports Positive Effect of Pepinemab Treatment on..
25/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202322:15EDGAR2Form SC 13D/A - General statement of acquisition of..
13/10/202322:54EDGAR2Form 8-K - Current report
12/10/202322:30EDGAR2Form SC 13D/A - General statement of acquisition of..
05/10/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 7,00 Min: 7,00 Max: 7,7999
Chiusura: 6,90

La tua Cronologia

NASDAQ
VCNX
Vaccinex
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network